Literature DB >> 24613926

Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.

Lei Ma1, Xubin Deng1, Minhua Wu2, Gong Zhang3, Jianqing Huang4.   

Abstract

Nasopharayngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated malignancy. It is known that microRNAs are implicated in the progression of NPC. However, the role of miR-204 in NPC is poorly understood. In this study, we found that miR-204 was down-regulated in NPC cells and tissues. Low-level expression of miR-204 was significantly associated with a more aggressive and poor prognostic phenotype of NPC. We further found that EBV-encoded latent membrane protein 1 (LMP-1) suppressed miR-204 expression by activating Stat-3. Cdc42 was identified as a direct target of miR-204. Mir-204 inhibited EBV positive C666-1 cell invasion and metastasis partly through targeting cdc42.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cdc42; Epstein–Barr virus; Latent membrane protein 1; Nasopharyngeal carcinoma; Stat-3; miR-204

Mesh:

Substances:

Year:  2014        PMID: 24613926     DOI: 10.1016/j.febslet.2014.02.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  41 in total

1.  Investigation on the association between thyroid tumorigeneses and herpesviruses.

Authors:  J F M Almeida; A H Campos; M A Marcello; N E Bufalo; C L Rossi; L H P Amaral; A B Marques; L L Cunha; C A Alvarenga; P C Tincani; A J Tincani; L S Ward
Journal:  J Endocrinol Invest       Date:  2017-03-08       Impact factor: 4.256

2.  The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.

Authors:  Yaoyong Lu; Tao Li; Ganbao Wei; Liangbo Liu; Qinsheng Chen; Lufei Xu; Kunqiang Zhang; Dehao Zeng; Rongwei Liao
Journal:  Tumour Biol       Date:  2016-03-28

3.  microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.

Authors:  Cheng Zhao; Lin Qi; Minfeng Chen; Longfei Liu; Weiqian Yan; Shiyu Tong; Xiongbing Zu
Journal:  Exp Ther Med       Date:  2015-07-09       Impact factor: 2.447

4.  miR-1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K-ras in nasopharyngeal carcinoma.

Authors:  Xi Chen; Jingxuan Shi; Jianwen Zhong; Zhenyun Huang; Xi Luo; Yaping Huang; Shuang Feng; Jianbo Shao; Dabo Liu
Journal:  Int J Exp Pathol       Date:  2016-01-19       Impact factor: 1.925

5.  Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis.

Authors:  Ferhat Demir; Alper Han Çebi; Mukaddes Kalyoncu
Journal:  Clin Rheumatol       Date:  2018-08-31       Impact factor: 2.980

6.  Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.

Authors:  Gengqiu Luo; Yanhong Zhou; Wei Yi; Hong Yi
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

7.  Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer.

Authors:  Weidong Li; Xuejun Jin; Qianbing Zhang; Gong Zhang; Xubin Deng; Lei Ma
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.

Authors:  Jun Zeng; Min Wei; Rong Shi; Cuixia Cai; Xinrui Liu; Taoping Li; Wenli Ma
Journal:  Tumour Biol       Date:  2015-09-25

Review 9.  MicroRNAs in pulmonary arterial hypertension.

Authors:  Guofei Zhou; Tianji Chen; J Usha Raj
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

10.  Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions.

Authors:  Jin Wang; Pamela L Paris; Jinyun Chen; Vy Ngo; Hui Yao; Marsha L Frazier; Ann M Killary; Chang-Gong Liu; Han Liang; Christian Mathy; Sandhya Bondada; Kimberly Kirkwood; Subrata Sen
Journal:  Cancer Lett       Date:  2014-10-07       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.